Drug Safety Solutions And Pharmacovigilance Market 2027 By Type, End Users | The Insight Partners

Drug Safety Solutions And Pharmacovigilance Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (Softwares, Services); End Users (Pharma and Biotech Companies, Contract Research Organizations (CROs), Business Process Outsourcing (BPO) Firms, Other Pharmacovigilance Service Providers)

Report Code: TIPRE00016854 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Drug Safety Solutions and pharmacovigilance consultancy and support services offered by market players in order to ensure pharmaceutical developers meet industry regulatory standards. The companies engaged in this business consistently updates its regulatory knowledge to keep up with industry trends. Various government regulatory bodies (such as the U.S. FDA and EMEA) have intensified safety regulations for prior and post commercialization of drugs, which has increased pressure on the pharmaceutical and biotechnology companies to manufacture safe drugs and evaluate their results post sales. Thus, growing complexity related to drug safety regulations is expected to drive the growth of the market during the forecast period.

MARKET DYNAMICS

Drug safety solutions and pharmacovigilance market is driving due to factors such as increase in R & D expenditure by pharmaceutical and biopharmaceutical companies and increase in the number of adverse drug reactions (ADRS). However, factors such as, high cost of drug safety solutions & pharmacovigilance services is expected to hamper the market growth.

MARKET SCOPE

The Drug safety solutions and pharmacovigilance market analysis to 2027 is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of Drug safety solutions and pharmacovigilance market with detailed market segmentation by model type, service, therapeutic area, technology and end user. The Drug safety solutions and pharmacovigilance market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in Drug safety solutions and pharmacovigilance market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The Drug safety solutions and pharmacovigilance market is segmented on the basis of type and end user. Based on type, the market is segmented as Softwares, Services. Based on end users, market is segmented as Pharma and Biotech Companies, Contract Research Organizations (CROs), Business Process Outsourcing (BPO) Firms, Other Pharmacovigilance Service Providers.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Drug safety solutions and pharmacovigilance market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Drug safety solutions and pharmacovigilance market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Drug safety solutions and pharmacovigilance market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Drug safety solutions and pharmacovigilance market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the Drug safety solutions and pharmacovigilance market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Drug safety solutions and pharmacovigilance market are anticipated to have lucrative growth opportunities in the future with the rising demand for Drug safety solutions and pharmacovigilance in the global market. Below mentioned is the list of few companies engaged in the Drug safety solutions and pharmacovigilance market.

The report also includes the profiles of key players in Drug safety solutions and Pharmacovigilance market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Pharmaceutical Product Development, LLC.
  •  Drug Safety Solutions Limited
  •  Syneos Health
  •  Worldwide Clinical Trials
  •  Bioclinica
  •  United Biosource LLC.
  •  Ennov
  •  IQVIA
  •  Covance Inc.
  •  Parexel International Corporation

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Drug Safety Solutions And Pharmacovigilance Market - By Type
1.3.2 Drug Safety Solutions And Pharmacovigilance Market - By End Users
1.3.3 Drug Safety Solutions And Pharmacovigilance Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. DRUG SAFETY SOLUTIONS AND PHARMACOVIGILANCE MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. DRUG SAFETY SOLUTIONS AND PHARMACOVIGILANCE MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. DRUG SAFETY SOLUTIONS AND PHARMACOVIGILANCE MARKET - GLOBAL MARKET ANALYSIS
6.1. DRUG SAFETY SOLUTIONS AND PHARMACOVIGILANCE - GLOBAL MARKET OVERVIEW
6.2. DRUG SAFETY SOLUTIONS AND PHARMACOVIGILANCE - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. DRUG SAFETY SOLUTIONS AND PHARMACOVIGILANCE MARKET - REVENUE AND FORECASTS TO 2027 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. SOFTWARES
7.3.1. Overview
7.3.2. Softwares Market Forecast and Analysis
7.4. SERVICES
7.4.1. Overview
7.4.2. Services Market Forecast and Analysis
8. DRUG SAFETY SOLUTIONS AND PHARMACOVIGILANCE MARKET - REVENUE AND FORECASTS TO 2027 - END USERS
8.1. OVERVIEW
8.2. END USERS MARKET FORECASTS AND ANALYSIS
8.3. PHARMA AND BIOTECH COMPANIES
8.3.1. Overview
8.3.2. Pharma and Biotech Companies Market Forecast and Analysis
8.4. CONTRACT RESEARCH ORGANIZATIONS (CROS)
8.4.1. Overview
8.4.2. Contract Research Organizations (CROs) Market Forecast and Analysis
8.5. BUSINESS PROCESS OUTSOURCING (BPO) FIRMS
8.5.1. Overview
8.5.2. Business Process Outsourcing (BPO) Firms Market Forecast and Analysis
8.6. OTHER PHARMACOVIGILANCE SERVICE PROVIDERS
8.6.1. Overview
8.6.2. Other Pharmacovigilance Service Providers Market Forecast and Analysis
9. DRUG SAFETY SOLUTIONS AND PHARMACOVIGILANCE MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Drug Safety Solutions And Pharmacovigilance Market Overview
9.1.2 North America Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis
9.1.3 North America Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis - By Type
9.1.4 North America Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis - By End Users
9.1.5 North America Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis - By Countries
9.1.5.1 United States Drug Safety Solutions And Pharmacovigilance Market
9.1.5.1.1 United States Drug Safety Solutions And Pharmacovigilance Market by Type
9.1.5.1.2 United States Drug Safety Solutions And Pharmacovigilance Market by End Users
9.1.5.2 Canada Drug Safety Solutions And Pharmacovigilance Market
9.1.5.2.1 Canada Drug Safety Solutions And Pharmacovigilance Market by Type
9.1.5.2.2 Canada Drug Safety Solutions And Pharmacovigilance Market by End Users
9.1.5.3 Mexico Drug Safety Solutions And Pharmacovigilance Market
9.1.5.3.1 Mexico Drug Safety Solutions And Pharmacovigilance Market by Type
9.1.5.3.2 Mexico Drug Safety Solutions And Pharmacovigilance Market by End Users
9.2. EUROPE
9.2.1 Europe Drug Safety Solutions And Pharmacovigilance Market Overview
9.2.2 Europe Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis
9.2.3 Europe Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis - By Type
9.2.4 Europe Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis - By End Users
9.2.5 Europe Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Drug Safety Solutions And Pharmacovigilance Market
9.2.5.1.1 Germany Drug Safety Solutions And Pharmacovigilance Market by Type
9.2.5.1.2 Germany Drug Safety Solutions And Pharmacovigilance Market by End Users
9.2.5.2 France Drug Safety Solutions And Pharmacovigilance Market
9.2.5.2.1 France Drug Safety Solutions And Pharmacovigilance Market by Type
9.2.5.2.2 France Drug Safety Solutions And Pharmacovigilance Market by End Users
9.2.5.3 Italy Drug Safety Solutions And Pharmacovigilance Market
9.2.5.3.1 Italy Drug Safety Solutions And Pharmacovigilance Market by Type
9.2.5.3.2 Italy Drug Safety Solutions And Pharmacovigilance Market by End Users
9.2.5.4 Spain Drug Safety Solutions And Pharmacovigilance Market
9.2.5.4.1 Spain Drug Safety Solutions And Pharmacovigilance Market by Type
9.2.5.4.2 Spain Drug Safety Solutions And Pharmacovigilance Market by End Users
9.2.5.5 United Kingdom Drug Safety Solutions And Pharmacovigilance Market
9.2.5.5.1 United Kingdom Drug Safety Solutions And Pharmacovigilance Market by Type
9.2.5.5.2 United Kingdom Drug Safety Solutions And Pharmacovigilance Market by End Users
9.2.5.6 Rest of Europe Drug Safety Solutions And Pharmacovigilance Market
9.2.5.6.1 Rest of Europe Drug Safety Solutions And Pharmacovigilance Market by Type
9.2.5.6.2 Rest of Europe Drug Safety Solutions And Pharmacovigilance Market by End Users
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Drug Safety Solutions And Pharmacovigilance Market Overview
9.3.2 Asia-Pacific Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis
9.3.3 Asia-Pacific Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis - By End Users
9.3.5 Asia-Pacific Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Drug Safety Solutions And Pharmacovigilance Market
9.3.5.1.1 Australia Drug Safety Solutions And Pharmacovigilance Market by Type
9.3.5.1.2 Australia Drug Safety Solutions And Pharmacovigilance Market by End Users
9.3.5.2 China Drug Safety Solutions And Pharmacovigilance Market
9.3.5.2.1 China Drug Safety Solutions And Pharmacovigilance Market by Type
9.3.5.2.2 China Drug Safety Solutions And Pharmacovigilance Market by End Users
9.3.5.3 India Drug Safety Solutions And Pharmacovigilance Market
9.3.5.3.1 India Drug Safety Solutions And Pharmacovigilance Market by Type
9.3.5.3.2 India Drug Safety Solutions And Pharmacovigilance Market by End Users
9.3.5.4 Japan Drug Safety Solutions And Pharmacovigilance Market
9.3.5.4.1 Japan Drug Safety Solutions And Pharmacovigilance Market by Type
9.3.5.4.2 Japan Drug Safety Solutions And Pharmacovigilance Market by End Users
9.3.5.5 South Korea Drug Safety Solutions And Pharmacovigilance Market
9.3.5.5.1 South Korea Drug Safety Solutions And Pharmacovigilance Market by Type
9.3.5.5.2 South Korea Drug Safety Solutions And Pharmacovigilance Market by End Users
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Drug Safety Solutions And Pharmacovigilance Market Overview
9.4.2 Middle East and Africa Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis
9.4.3 Middle East and Africa Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis - By End Users
9.4.5 Middle East and Africa Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Drug Safety Solutions And Pharmacovigilance Market
9.4.5.1.1 South Africa Drug Safety Solutions And Pharmacovigilance Market by Type
9.4.5.1.2 South Africa Drug Safety Solutions And Pharmacovigilance Market by End Users
9.4.5.2 Saudi Arabia Drug Safety Solutions And Pharmacovigilance Market
9.4.5.2.1 Saudi Arabia Drug Safety Solutions And Pharmacovigilance Market by Type
9.4.5.2.2 Saudi Arabia Drug Safety Solutions And Pharmacovigilance Market by End Users
9.4.5.3 U.A.E Drug Safety Solutions And Pharmacovigilance Market
9.4.5.3.1 U.A.E Drug Safety Solutions And Pharmacovigilance Market by Type
9.4.5.3.2 U.A.E Drug Safety Solutions And Pharmacovigilance Market by End Users
9.4.5.4 Rest of Middle East and Africa Drug Safety Solutions And Pharmacovigilance Market
9.4.5.4.1 Rest of Middle East and Africa Drug Safety Solutions And Pharmacovigilance Market by Type
9.4.5.4.2 Rest of Middle East and Africa Drug Safety Solutions And Pharmacovigilance Market by End Users
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Drug Safety Solutions And Pharmacovigilance Market Overview
9.5.2 South and Central America Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis
9.5.3 South and Central America Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis - By Type
9.5.4 South and Central America Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis - By End Users
9.5.5 South and Central America Drug Safety Solutions And Pharmacovigilance Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Drug Safety Solutions And Pharmacovigilance Market
9.5.5.1.1 Brazil Drug Safety Solutions And Pharmacovigilance Market by Type
9.5.5.1.2 Brazil Drug Safety Solutions And Pharmacovigilance Market by End Users
9.5.5.2 Argentina Drug Safety Solutions And Pharmacovigilance Market
9.5.5.2.1 Argentina Drug Safety Solutions And Pharmacovigilance Market by Type
9.5.5.2.2 Argentina Drug Safety Solutions And Pharmacovigilance Market by End Users
9.5.5.3 Rest of South and Central America Drug Safety Solutions And Pharmacovigilance Market
9.5.5.3.1 Rest of South and Central America Drug Safety Solutions And Pharmacovigilance Market by Type
9.5.5.3.2 Rest of South and Central America Drug Safety Solutions And Pharmacovigilance Market by End Users
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL DRUG SAFETY SOLUTIONS AND PHARMACOVIGILANCE MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. DRUG SAFETY SOLUTIONS AND PHARMACOVIGILANCE MARKET, KEY COMPANY PROFILES
12.1. PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. DRUG SAFETY SOLUTIONS LIMITED
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. SYNEOS HEALTH
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. WORLDWIDE CLINICAL TRIALS
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BIOCLINICA
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. UNITED BIOSOURCE LLC
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ENNOV
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. IQVIA
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. COVANCE INC.
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. PAREXEL INTERNATIONAL CORPORATION
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Pharmaceutical Product Development, LLC.
2. Drug Safety Solutions Limited
3. Syneos Health
4. Worldwide Clinical Trials
5. Bioclinica
6. United Biosource LLC.
7. Ennov
8. IQVIA
9. Covance Inc.
10. Parexel International Corporation
TIPRE00016854
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking